Patents by Inventor Gary Woodnutt

Gary Woodnutt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating viral diseases with il-18 and il-18 combinations
    Publication number: 20030113292
    Abstract: The present invention relates generally to the use of compositions comprising IL-18, also known as interferon-&ggr;-inducing factor (IGIF), and IL-18 in combination with other agents, for the prevention and/or treatment of viral diseases caused by HIV, HSV, HPV, HAV, HBV, and HCV.
    Type: Application
    Filed: December 2, 2002
    Publication date: June 19, 2003
    Inventors: Klaus M Esser, Martin Rosenberg, Ruth Tal-Singer, Gary Woodnutt, Francis V Chisari, Susan B Dillon
  • Use of PDE 4-specific inhibitors to reduce the severity of a bacterial infection after a respiratory viral infection
    Patent number: 6436971
    Abstract: This invention relates to a method for the prophylaxis of or reducing the severity of post-viral bacterial infection by administering a PDE 4-specific inhibitor prior to or during the course of a viral infection or thereafter during the course of the bacterial infection.
    Type: Grant
    Filed: February 8, 2001
    Date of Patent: August 20, 2002
    Assignee: SmithKline Beecham Corporation
    Inventors: Peter L. DeMarsh, Susan B. Dillon, Gary Woodnutt
  • Use of PDE-4-specific inhibitors to reduce the severity of a bacterial infection after a respiratory viral infection
    Publication number: 20010041739
    Abstract: This invention relates to a method for the prophylaxis of or reducing the severity of post-viral bacterial infection by administering a PDE 4-specific inhibitor prior to or during the course of a viral infection or thereafter during the course of the bacterial infection.
    Type: Application
    Filed: February 8, 2001
    Publication date: November 15, 2001
    Inventors: Peter L. DeMarsh, Susan B. Dillon, Gary Woodnutt
  • Pleuromutilin derivatives as antimicrobials
    Patent number: 6281226
    Abstract: The present invention relates to pleuromutilin derivatives, to processes for their preparation, to pharmaceutical compositions containing them and to their use in medical therapy, particularly antibacterial therapy.
    Type: Grant
    Filed: April 27, 2000
    Date of Patent: August 28, 2001
    Assignee: SmithKline Beecham p.l.c.
    Inventors: Valerie Berry, Steven Dabbs, Colin Henry Frydrych, Eric Hunt, Francis Dominic Sanderson, Gary Woodnutt
  • Pleuromutilin derivatives as antimicrobials
    Patent number: RE39128
    Abstract: The present invention relates to pleuromutilin derivatives, to processes for their preparation, to pharmaceutical compositions containing them and to their use in medical therapy, particularly antibacterial therapy.
    Type: Grant
    Filed: October 27, 1998
    Date of Patent: June 13, 2006
    Assignee: SmithKline Beecham p.l.c.
    Inventors: Valerie Joan Berry, Steven Dabbs, Colin Henry Frydrych, Eric Hunt, Francis Dominic Sanderson, Gary Woodnutt
  • Pleuromutilin derivatives as antimicrobials
    Patent number: RE43390
    Abstract: The present invention relates to pleuromutilin derivatives, to processes for their preparation, to pharmaceutical compositions containing them and to their use in medical therapy, particularly antibacterial therapy.
    Type: Grant
    Filed: October 27, 1998
    Date of Patent: May 15, 2012
    Assignees: GlaxoSmithKline LLC, SmithKline Beecham Limited
    Inventors: Valerie Joan Berry, Steven Dabbs, Colin Henry Frydrych, Eric Hunt, Francis Dominic Sanderson, Gary Woodnutt